DiscoverClinical MindsThe importance of community building, patient trust, and improving access to cancer clinical trials with Dana Dornsife
The importance of community building, patient trust, and improving access to cancer clinical trials with Dana Dornsife

The importance of community building, patient trust, and improving access to cancer clinical trials with Dana Dornsife

Update: 2021-12-01
Share

Description

Currently our black and brown communities are really grossly underrepresented in cancer clinical trials, and we need to fix that. Historical barriers around egregious medical behaviors that have taken place in the past, cultural barriers, language barriers, and finally socioeconomic barriers impact the outcome of someone’s cancer journey,” says Dana Dornsife, founder and CEO at Lazarex Cancer Foundation, a nationwide non-profit org she founded in 2006.

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

The importance of community building, patient trust, and improving access to cancer clinical trials with Dana Dornsife

The importance of community building, patient trust, and improving access to cancer clinical trials with Dana Dornsife

Medidata